2018
DOI: 10.48550/arxiv.1806.06163
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A Micro-Scale Mobile-Enabled Implantable Medical Sensor

Abstract: Micro-scale implantable medical devices (IMDs) extend the immense benefits of sensors used in health management. However, their development is limited by many requirements and challenges, such as the use of safe materials, size restrictions, safe and efficient powering, and selection of suitable wireless communication technologies. Some of the proposed wireless communication technologies are the terahertz (THz) radio frequency (RF), and ultrasound. This paper investigates the use of magnetic induction-based ba… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 37 publications
(51 reference statements)
0
1
0
Order By: Relevance
“…In EM-based and acoustic communication and power transfer processes, for example, the biocompatibility is crucial for preventing the damage on biochemical structures, e.g., tissue damage by heating, and closely linked to the frequency and power of the EM or acoustic waves. For human body applications, the exposure limits are regulated by the Food and Drug Administration (FDA) in US, as 100 µW/mm 2 for RF waves and 7.2 mW/mm 2 for ultrasound waves, [125], [179]. These limits should be taken into account in the design of IoBNT technologies.…”
Section: Biocompatibility and Co-existencementioning
confidence: 99%
“…In EM-based and acoustic communication and power transfer processes, for example, the biocompatibility is crucial for preventing the damage on biochemical structures, e.g., tissue damage by heating, and closely linked to the frequency and power of the EM or acoustic waves. For human body applications, the exposure limits are regulated by the Food and Drug Administration (FDA) in US, as 100 µW/mm 2 for RF waves and 7.2 mW/mm 2 for ultrasound waves, [125], [179]. These limits should be taken into account in the design of IoBNT technologies.…”
Section: Biocompatibility and Co-existencementioning
confidence: 99%